Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27500) 27500
Newspaper Article (6407) 6407
Newsletter (2253) 2253
Publication (2028) 2028
Web Resource (620) 620
Magazine Article (482) 482
Book Review (370) 370
Book Chapter (358) 358
Trade Publication Article (202) 202
Book / eBook (93) 93
Government Document (90) 90
Dissertation (67) 67
Conference Proceeding (55) 55
Streaming Video (42) 42
Report (39) 39
Data Set (18) 18
Reference (17) 17
Transcript (11) 11
Journal / eJournal (4) 4
Paper (2) 2
Presentation (2) 2
Microfilm (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
botulinum toxin (20170) 20170
humans (14710) 14710
index medicus (8194) 8194
female (7562) 7562
male (7202) 7202
animals (4951) 4951
middle aged (4703) 4703
adult (4693) 4693
botulinum toxins, type a - therapeutic use (4209) 4209
treatment outcome (3660) 3660
clinical neurology (3341) 3341
surgery (3304) 3304
botulinum toxins, type a - administration & dosage (3148) 3148
aged (3093) 3093
neuromuscular agents - therapeutic use (2928) 2928
research (2653) 2653
botulinum toxins - therapeutic use (2577) 2577
double-blind (2468) 2468
care and treatment (2390) 2390
neurosciences (2122) 2122
neuromuscular agents - administration & dosage (1958) 1958
injections, intramuscular (1781) 1781
mice (1767) 1767
injections (1748) 1748
spasticity (1586) 1586
clostridium botulinum (1580) 1580
botulinum toxins (1500) 1500
child (1492) 1492
adolescent (1465) 1465
pain (1464) 1464
dermatology (1442) 1442
rehabilitation (1405) 1405
health aspects (1389) 1389
botulinum toxin type a (1375) 1375
botulinum toxins - administration & dosage (1360) 1360
analysis (1351) 1351
botulism (1337) 1337
management (1316) 1316
botulinum toxins - pharmacology (1288) 1288
dystonia (1287) 1287
rats (1254) 1254
medicine & public health (1239) 1239
biochemistry & molecular biology (1197) 1197
efficacy (1193) 1193
follow-up studies (1167) 1167
time factors (1159) 1159
injection (1156) 1156
botulinum toxins, type a - adverse effects (1150) 1150
toxin type-a (1077) 1077
prospective studies (1041) 1041
cervical dystonia (1040) 1040
retrospective studies (1027) 1027
botulinum-toxin (1010) 1010
medicine (1002) 1002
usage (1001) 1001
pharmacology & pharmacy (993) 993
migraine (981) 981
cerebral palsy (971) 971
botulinum toxins, type a - pharmacology (958) 958
toxins (958) 958
urology & nephrology (956) 956
drug therapy (953) 953
medical research (947) 947
toxin (947) 947
neurology (943) 943
children (927) 927
pediatrics (924) 924
aged, 80 and over (911) 911
botulinum toxin a (905) 905
otorhinolaryngology (895) 895
quality of life (888) 888
skin (884) 884
therapy (882) 882
stroke (869) 869
botulinum neurotoxin (868) 868
child, preschool (857) 857
dose-response relationship, drug (857) 857
young adult (853) 853
botulinum-toxin-a (834) 834
proteins (834) 834
medicine, general & internal (825) 825
microbiology (819) 819
muscle spasticity - drug therapy (815) 815
electromyography (801) 801
reports (801) 801
clostridium-botulinum (793) 793
patients (781) 781
plastic surgery (779) 779
ophthalmology (768) 768
safety (764) 764
toxicology (753) 753
abridged index medicus (747) 747
medicine, experimental (729) 729
clinical trials (726) 726
gastroenterology & hepatology (722) 722
anti-dyskinesia agents - therapeutic use (709) 709
quality-of-life (696) 696
botulinum toxins - metabolism (694) 694
diagnosis (681) 681
neuromuscular agents - adverse effects (681) 681
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (49) 49
Gerstein Science - Stacks (24) 24
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Gerstein Science - Missing (4) 4
Gerstein Science - Circulation Desk (3) 3
UofT at Mississauga - Stacks (3) 3
Robarts - Stacks (2) 2
Scarborough Hospital - Online (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34263) 34263
German (1050) 1050
French (725) 725
Spanish (524) 524
Russian (314) 314
Japanese (207) 207
Portuguese (187) 187
Polish (161) 161
Korean (140) 140
Turkish (99) 99
Chinese (85) 85
Czech (53) 53
Dutch (50) 50
Italian (45) 45
Norwegian (24) 24
Danish (21) 21
Finnish (21) 21
Hebrew (15) 15
Hungarian (15) 15
Swedish (14) 14
Croatian (9) 9
Serbian (9) 9
Ukrainian (9) 9
Slovak (8) 8
Persian (7) 7
Slovenian (6) 6
Bosnian (3) 3
Catalan (3) 3
Romanian (3) 3
Hindi (2) 2
Lithuanian (2) 2
Urdu (2) 2
Bulgarian (1) 1
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Botulinum toxin
by Carruthers, Alastair and Carruthers, Jean
2008, 2nd ed., Procedures in cosmetic dermatology, ISBN 141604213X, 131
Care and hygiene | Skin Care | Dermatologic agents | Botulinum Toxin A | Skin | Botulinum toxin | Therapeutic use
Book
Details down arrow
2. Botulinum toxin
by Carruthers, Alastair and Carruthers, Jean
2013, 3rd ed., Procedures in cosmetic dermatology, ISBN 1455727814
Care and hygiene | Cosmetic Techniques | Dermatologic agents | Skin | Neck | Face | Botulinum toxin | Therapeutic use
Web Resource
Details down arrow
3. Botulinum toxins
: cosmetic and clinical applications
by Cohen, Joel L. (Dermatologist) and Ozog, David M
2017, ISBN 9781118661864
Botulinum Toxins, Type A | Cosmetic Techniques | therapeutic use
Web Resource
Details down arrow
4. Botulinum toxin
: therapeutic clinical practice and science
by Albanese, Alberto and Atassi, M and Dolly, J and Hallett, Mark and Mayer, Nathaniel
2009, 1, ISBN 1416049282, xv, 493
The new, therapeutically-focused Botulinum Toxin presents comprehensive, cross-disciplinary guidance on current practices, covering more than 100 non-cosmetic... 
Botulinum toxin
Book
Details down arrow
5. Full Text The convergence of medicine and neurotoxins: A focus on botulinum toxin type A and its application in aesthetic medicine - A global, evidence-based botulinum toxin consensus education initiative: Part II: Incorporating botulinum toxin into aesthetic clinical practice
by Carruthers, Jean and Fournier, Nathalie and Kerscher, Martina and Ruiz-Avila, Javier and Trindade De Almeida, Ada R and Kaeuper, Gina
Dermatologic Surgery, ISSN 1076-0512, 03/2013, Volume 39, Issue 3, pp. 510 - 525
The new world of safe aesthetic injectables has become increasingly popular with patients. Not only is there less risk than with surgery, but there is also... 
Botulinum Toxins, Type A - therapeutic use | Injections - adverse effects | Cosmetic Techniques | Humans | Botulinum Toxins, Type A - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The convergence of medicine and neurotoxins: A focus on botulinum toxin type A and its application in aesthetic medicine - A global, evidence-based botulinum toxin consensus education initiative: Part I: Botulinum toxin in clinical and cosmetic practice
by Carruthers, Alastair and Kane, Michael A. C and Flynn, Timothy C and Huang, Peter and Kim, Sang D and Solish, Nowell and Kaeuper, Gina
Dermatologic Surgery, ISSN 1076-0512, 03/2013, Volume 39, Issue 3, pp. 493 - 509
The U.S. Food and Drug Administration has approved four distinct formulations of botulinum toxin (BoNT) serotypes A and B (BoNTA and BoNTB) for medical use.... 
Botulinum Toxins - therapeutic use | Botulinum Toxins, Type A - therapeutic use | Cosmetic Techniques | Humans | Botulinum Toxins - adverse effects | Botulinum Toxins - administration & dosage | Chemistry, Pharmaceutical
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX°) in healthy volunteers
by Jost, W. H and Kohl, A and Brinkmann, S and Comes, G
Journal of Neural Transmission, ISSN 0300-9564, 6/2005, Volume 112, Issue 7, pp. 905 - 913
Purpose: This randomized controlled trial was performed to compare the novel botulinum toxin type A free of complexing proteins (NT 201) with the marketed... 
Botulinum toxin type A, EDB test, NT 201 | Neurology | Medicine & Public Health | Pharmacology/Toxicology | Psychiatry | NT 201 | Botulinum toxin type A | EDB test | NEUROTOXIN SEROTYPE-A | SAFETY | INJECTION | HUMANS | CERVICAL DYSTONIA | botulinum toxin type A | NEUROSCIENCES | CLINICAL NEUROLOGY | Botulinum Toxins, Type A - pharmacology | Neuromuscular Agents - chemistry | Time Factors | Humans | Middle Aged | Muscle, Skeletal - drug effects | Bacterial Proteins - chemistry | Botulinum Toxins, Type A - chemistry | Neuromuscular Agents - pharmacology | Adult | Male | Action Potentials - drug effects | Proteins | Comparative analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Five‐year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins
by Dressler, D
European Journal of Neurology, ISSN 1351-5101, 03/2012, Volume 19, Issue 3, pp. 385 - 389
In 2005, incobotulinumtoxinA (Xeomin ® ), a new botulinum toxin (BT) type A drug without complexing proteins (CPs), became available. This paper reviews the... 
complexing proteins | incobotulinumtoxinA | botulinum toxin type A | long‐term follow‐up | therapeutic use | Long-term follow-up | Botulinum toxin type A | Complexing proteins | IncobotulinumtoxinA | Therapeutic use | EFFICACY | C. BOTULINUM | ANTIBODY | NEUROTOXIN TYPE-A | NEUROSCIENCES | CLINICAL NEUROLOGY | CLOSTRIDIUM-BOTULINUM | THERAPY | DISSOCIATION | long-term follow-up | PHYSIOLOGICAL CONDITIONS | CERVICAL DYSTONIA | LONG-TERM TREATMENT | Neuromuscular Agents - chemistry | Botulinum Toxins, Type A - therapeutic use | Animals | Neuromuscular Agents - immunology | Drug Stability | Humans | Botulinum Toxins, Type A - chemistry | Botulinum Toxins, Type A - immunology | Neuromuscular Agents - therapeutic use | Drugs | Proteins | Botulism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Botulinum toxin
: therapeutic clinical practice and science
by Jankovic, Joseph and ScienceDirect (Online service)
2009, ISBN 1416049282
The new, therapeutically-focused Botulinum Toxin presents comprehensive, cross-disciplinary guidance on current practices, covering more than 100 non-cosmetic... 
Botulinum Toxins | Botulinum toxin | Therapeutic use
Web Resource
Details down arrow
10. Botulinum toxin
: therapeutic clinical practice and science
by Jankovic, Joseph
2009, ISBN 1416049282
Botulinum Toxins | Botulinum toxin | Therapeutic use
Web Resource
Details down arrow
11. Botulinum toxin
: therapeutic clinical practice and science
by Jankovic, Joseph
2009, ISBN 1416049282
Botulinum toxin | Therapeutic use
Web Resource
Details down arrow
12. Full Text Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study
by Peyronnet, Benoit and Castel‐Lacanal, Evelyne and Roumiguie, Mathieu and Even, Lucie and Marque, Philippe and Soulié, Michel and Rischmann, Pascal and Game, Xavier
Neurourology and Urodynamics, ISSN 0733-2467, 03/2017, Volume 36, Issue 3, pp. 734 - 739
AimsTo compare the outcomes of the first intradetrusor injections of abobotulinum toxin 750U and onabotulinum toxin 200 and 300U in patients with neurogenic... 
botulinum toxin | onabotulinum toxin | neurogenic bladder | abobotulinum toxin | detrusor overactivity | CONTROLLED-TRIAL | EFFICACY | TOLERABILITY | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | BOTULINUM-TOXIN | URINARY-INCONTINENCE | Humans | Middle Aged | Urodynamics - drug effects | Male | Treatment Outcome | Neuromuscular Agents - therapeutic use | Urinary Bladder, Neurogenic - drug therapy | Botulinum Toxins, Type A - administration & dosage | Case-Control Studies | Dose-Response Relationship, Drug | Botulinum Toxins, Type A - therapeutic use | Urinary Bladder, Overactive - drug therapy | Neuromuscular Agents - administration & dosage | Adult | Female | Retrospective Studies | Administration, Intravesical | Botulinum toxin | Toxin A | Success | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Botulinum-toxin therapy
by Dressler, Dirk
2000, ISBN 3131176911, xi, 192
Chemotherapy | Dystonia | Botulinum toxin | Therapeutic use | Spasms
Book
Details down arrow
14. Full Text Botulinum toxin type B vs. type A in toxin‐naïve patients with cervical dystonia: Randomized, double‐blind, noninferiority trial
by Pappert, Eric J and Germanson, Terry and Myobloc Neurobloc European Cervica and Myobloc/Neurobloc European Cervical Dystonia Study Group and The Myobloc/Neurobloc European Cervical Dystonia Study Group
Movement Disorders, ISSN 0885-3185, 03/2008, Volume 23, Issue 4, pp. 510 - 517
The objective of this study was to compare efficacy, safety, and duration of botulinum toxin type A (BoNT‐A) and type B (BoNT‐B) in toxin‐naïve cervical... 
toxin‐naïve | cervical dystonia | botulinum toxin type B | botulinum toxin type A | Botulinum toxin type B | Botulinum toxin type A | Cervical dystonia | Toxin-naïve | toxin-naive | RESISTANT | EFFICACY | SAFETY | SEROTYPE-A | CLINICAL NEUROLOGY | Disability Evaluation | Severity of Illness Index | Double-Blind Method | Torticollis - diagnosis | Humans | Middle Aged | Male | Treatment Outcome | Neuromuscular Agents - therapeutic use | Botulinum Toxins - therapeutic use | Botulinum Toxins, Type A - therapeutic use | Injections | Torticollis - complications | Torticollis - drug therapy | Neuromuscular Agents - adverse effects | Pain - etiology | Female | Botulinum Toxins - adverse effects | Pain Measurement | Xerostomia - epidemiology | Xerostomia - chemically induced | Botulinum Toxins, Type A - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Manual of botulinum toxin therapy
by Truong, Daniel, M.D and Dressler, Dirk and Hallett, Mark, 1943
2009, 1, Cambridge medicine, ISBN 0521694426, xvi, 218
The Manual of Botulinum Toxin Therapy provides practical guidance on the use of botulinum toxin in a wide variety of disorders, in many areas of medicine.... 
Botulinum Toxins | drug therapy | Neuromuscular Diseases | pharmacology | Movement Disorders | Botulinum toxin | Therapeutic use | Clinical & internal medicine | Handbooks, manuals, etc | Internal medicine
Book
Details down arrow
16. Full Text Botulinum toxin type A (BOTOX®) for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial
by Mathew, Ninan T and Frishberg, Benjamin M and Gawel, Marek and Dimitrova, Rozalina and Gibson, John and Turkel, Catherine and BOTOX CDH Study Group
Headache, ISSN 0017-8748, 04/2005, Volume 45, Issue 4, pp. 293 - 307
Objective.-The objective of this study was to evaluate the safety and efficacy of botulinum toxin type A (BoNT-A; BOTOX(R), Allergan, Inc.) for the... 
Migraine headache | Double-blind | Botulinum toxin type A | Placebo-controlled | Prophylaxis | Chronic daily headache | chronic daily headache | CLASSIFICATION | TOPIRAMATE | PREVALENCE | botulinum toxin type A | prophylaxis | CLINICAL NEUROLOGY | NEAR-DAILY HEADACHES | PREVENTIVE TREATMENT | THERAPY | MIGRAINE PREVENTION | placebo-controlled | IHS CRITERIA | double-blind | migraine headache | Single-Blind Method | Headache Disorders - prevention & control | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Neuromuscular Agents - therapeutic use | Botulinum Toxins, Type A - therapeutic use | Adolescent | Adult | Female | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Clostridium difficile Toxin Biology
by Aktories, Klaus and Schwan, Carsten and Jank, Thomas
Annual Review of Microbiology, ISSN 0066-4227, 9/2017, Volume 71, Issue 1, pp. 281 - 307
Clostridium difficile is the cause of antibiotics-associated diarrhea and pseudomembranous colitis. The pathogen produces three protein toxins: C. difficile... 
infection | CDT | actin | ADP ribosylation | transferase toxin | Clostridium difficile | toxins | toxin uptake | glucosylation | microtubules | Rho proteins | toxin receptors | Toxin uptake | Actin | Microtubules | Clostridium difficile transferase toxin | Glucosylation | Clostridium difficile toxins | Clostridium difficile infection | Toxin receptors | A-INDUCED ENTERITIS | PERFRINGENS TPEL TOXIN | PYRIN INFLAMMASOME ACTIVATION | MICROBIOLOGY | STIMULATED LIPOPROTEIN RECEPTOR | GTP-BINDING PROTEINS | CYSTEINE PROTEASE DOMAIN | INTESTINAL EPITHELIAL-CELLS | INDUCED CONFORMATIONAL-CHANGES | BOTULINUM C2 TOXIN | TIGHT JUNCTION PERMEABILITY | ADP Ribose Transferases - toxicity | Enterotoxins - toxicity | Epithelial Cells - drug effects | Humans | Bacterial Toxins - toxicity | Epithelial Cells - physiology | Bacterial Toxins - metabolism | Endocytosis | Animals | Bacterial Proteins - toxicity | Microtubules - drug effects | Enterotoxins - metabolism | Bacterial Proteins - metabolism | Virulence Factors - metabolism | Clostridium difficile - metabolism | Cytoskeleton - drug effects | ADP Ribose Transferases - metabolism | Virulence Factors - toxicity | Bacterial toxins | Chemical properties | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights